<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EBF62057-C51F-47BB-9B80-D3AA4A7ACD29"><gtr:id>EBF62057-C51F-47BB-9B80-D3AA4A7ACD29</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>B.</gtr:otherNames><gtr:surname>Dunnett</gtr:surname><gtr:orcidId>0000-0003-1826-1578</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/53E7EF11-FCED-4F39-89E8-38E69990FC29"><gtr:id>53E7EF11-FCED-4F39-89E8-38E69990FC29</gtr:id><gtr:firstName>Anne Elizabeth</gtr:firstName><gtr:surname>Rosser</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500794"><gtr:id>70534207-8C21-4B51-8E31-E20550D7AEC9</gtr:id><gtr:title>Development and validation of functional cell therapies for Huntington's and Parkinson's diseases</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500794</gtr:grantReference><gtr:abstractText>Involving neural tissue transplantation in the brain, as well as stem cells, human embryos and animal experiments, this research is high profile in the general as well as scientific news media. In addition to publication in peer reviewed journals, the results of the present project will be widely disseminated to the biomedical research community, to NHS and clinical professions, and to interested charities and the lay public, through lectures and seminars in the normal way as well as in media interviews when appropriate. The PIs already have extensive experience in public communication of research results. We strive to achieve the best balance between the competing demands of proper disclosure of publicly funded science, public education, promoting enthusiasm for science and support for the MRC and biomedical research, but without raising false or premature hopes for cures that remain distant. The credibility of the team is enhanced by the close collaboration of the two PIs, one a basic scientist and the other a clinical scientist, combining resources and expertise to develop a translational programme for novel cell-based treatments for crippling human neurodegenerative diseases, spanning basic cellular, molecular and behavioural science through to clinical delivery in patients.</gtr:abstractText><gtr:technicalSummary>The UK is taking an international lead in developing stem cells for cell-based therapy applicable to a broad range of diseases. However, for these new sources of cells to come to effective application in the clinic requires that they are first evaluated and validated for specificity and functional potential in appropriate model systems, both in vitro and in vivo. 

The proposed project establishes quality-controlled processing of cells in vitro, determines optimal dissection, preparation handling and transplantation protocols, develops the experimental models for functional analysis, and refines our understanding of the theoretical principles and mechanisms of function for application of cell-based therapies in two specific human neurodegenerative diseases, Huntington?s and Parkinson?s. The programme sustains a centre of expertise developing the quality-controlled facilities necessary to progress specific cell sources (fetal now, expanded progenitors imminently, and stem cells in the foreseeable future) to clinical application rapidly and efficiently.</gtr:technicalSummary><gtr:fund><gtr:end>2011-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1601156</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>EU FP6 StemStroke</gtr:description><gtr:id>5FA4CA16-F166-4B57-9E38-CF4DC35DFE0B</gtr:id><gtr:impact>Development of new method of MCAO occlusion with improved animal welfare Characterisation of motor and cognitive deficits after unilateral striatal stroke Evaluation of efficacy of primary striatal cell transplantation in stoke models. Publications pending</gtr:impact><gtr:outcomeId>6BCAC14292B-1</gtr:outcomeId><gtr:partnerContribution>Development of MCAO lesion model and stem cell transplantation and behavioural analysistraining in MCAO models and collaboration in cell grafting, imaging technology and behaviour</gtr:partnerContribution><gtr:piContribution>Development of behavioural analysis and functional assessment of neural grafts in animal models of striatal stroke.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Institute for Neurological Research</gtr:department><gtr:description>EU FP6 StemStroke</gtr:description><gtr:id>66EEC199-E7CD-47A1-828F-A4566A8F8A8B</gtr:id><gtr:impact>Development of new method of MCAO occlusion with improved animal welfare Characterisation of motor and cognitive deficits after unilateral striatal stroke Evaluation of efficacy of primary striatal cell transplantation in stoke models. Publications pending</gtr:impact><gtr:outcomeId>6BCAC14292B-2</gtr:outcomeId><gtr:partnerContribution>Development of MCAO lesion model and stem cell transplantation and behavioural analysistraining in MCAO models and collaboration in cell grafting, imaging technology and behaviour</gtr:partnerContribution><gtr:piContribution>Development of behavioural analysis and functional assessment of neural grafts in animal models of striatal stroke.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>10-15 presentations to HDA and PDS patient groups</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>9B25C296-9EDE-4B60-992B-A873E9EC37BD</gtr:id><gtr:impact>10-15 presentations to HDA and PDS patient groups. I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

academic, medical and patient contacts</gtr:impact><gtr:outcomeId>014EB56EA63</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>results included in multiple public and academic lectures and seminars</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CFD62A8B-F6B9-431E-887A-F7FB1CBD5E89</gtr:id><gtr:impact>results included in multiple public and academic lectures and seminars

various</gtr:impact><gtr:outcomeId>2B80FAEA334</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>10-15 presentations to HDA and PDS patient groups.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>8DB7606E-7FA6-4A65-9719-E7976D700D3E</gtr:id><gtr:impact>I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

various</gtr:impact><gtr:outcomeId>757CF680ED8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>results included in multiple public and academic lectures and seminars</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>2EF6DE4B-2B0A-479E-8312-5A1CDF272D33</gtr:id><gtr:impact>results included in multiple public and academic lectures and seminars

various</gtr:impact><gtr:outcomeId>A1F186CD181</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>10-15 presentations to HDA and PDS patient groups.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>57916B84-28C9-46EF-BBD7-C4F6EE687218</gtr:id><gtr:impact>I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

various</gtr:impact><gtr:outcomeId>23C57C21F20</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>10-15 presentations to HDA and PDS patient groups.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B70AA7AA-3946-4DC3-81A7-F8DBE92DBBA9</gtr:id><gtr:impact>10-15 presentations to HDA and PDS patient groups. I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

various</gtr:impact><gtr:outcomeId>4E533867798</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>249934</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Welsh Office of Research and Development (WORD)</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Health and Care Research Wales</gtr:fundingOrg><gtr:id>E8B98107-7C84-456D-B3E2-80F161EEE630</gtr:id><gtr:outcomeId>D2B0418B2950</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>310115</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PDS project grants</gtr:description><gtr:end>2008-08-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>EB3836DC-76A1-4C20-A58E-8687184ECF4C</gtr:id><gtr:outcomeId>8D9911E07250</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1728580</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NEUROSTEMCELL European Consortium for Stem Cell Therapy in Neurodegenerative Diseases (12m euros across 16 participants)</gtr:description><gtr:end>2012-11-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>31685690-6254-447C-8B3D-34983D0BCF6C</gtr:id><gtr:outcomeId>1CFB5205CC00</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>262342</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>STEMSTROKE Towards a stem cell therapy for stroke (2.5m euros across 6 participants)</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>FA6F6F69-3498-4C10-9A6F-B1BDE507CDB7</gtr:id><gtr:outcomeId>01CBF13D1530</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>497251</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CHDI contract grants</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>CHDI Foundation</gtr:fundingOrg><gtr:id>C58D00DF-5914-4395-B115-B3BFDC943006</gtr:id><gtr:outcomeId>CC1100593CB0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1340940</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2010-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>60B5D556-5AF5-4911-81A4-4ECA159AEEB7</gtr:id><gtr:outcomeId>74B5BE98DCE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC stem cells</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>80791620-EB2B-450B-8811-E0B4E04664A8</gtr:id><gtr:impact>I participate in the MRC Stem Cell Bank User's group and participate regularly in MRC stem cell policy and funding strategy meetings at Head Office.</gtr:impact><gtr:outcomeId>046F92CC2E5</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>regular citations in clinical reviews and publications</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6682E4DC-C029-485C-AC41-91F844E8E278</gtr:id><gtr:impact>influence on development of NECTAR and ASNTR guidelines</gtr:impact><gtr:outcomeId>35DB9587696</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citations in clinical guidelines and reviews</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>7EC3AE41-F2A0-4BC8-92E5-EC6A8502E08E</gtr:id><gtr:impact>we contribute to ongoing debate and updating of guidelines on ethical sourcing of human fetal tissues for research and clinical cell transplantation.</gtr:impact><gtr:outcomeId>0A7A1912D35</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Stem Cells</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>F69ACDEE-1C51-4C6A-ABF3-5C8A84A8E872</gtr:id><gtr:impact>I participate in the MRC UK Stem Cell Bank users group and contribute regularly to the policy discussions at head office on stem cell strategy and funding.</gtr:impact><gtr:outcomeId>7E9135DE564</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>GTAC</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>6D85818D-6594-4E85-97FC-FEE8083BD0AE</gtr:id><gtr:impact>development of national ethical and regulatory guidelines</gtr:impact><gtr:outcomeId>2F7263565E5</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>F8BF9BF6-5B34-4A0D-8937-66F688D6F3B4</gtr:id><gtr:impact>Targetted direction, policy and funding of UK stem cell research .</gtr:impact><gtr:outcomeId>5AA8378353A</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC stem cell</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>BBE62CF2-4131-4399-8E05-7D3A4FBD9C2F</gtr:id><gtr:impact>I participate in the MRC Stem Cell Bank User's group and participate regularly in MRC stem cell policy and funding strategy meetings at Head Office.</gtr:impact><gtr:outcomeId>F2D8A6F3BAF</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>GTAC</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>2482D52E-A5EA-4432-AD56-5B217E75C15B</gtr:id><gtr:impact>member of GTAC committee reviewing applications and developing policy on stem cell and gene therapy trials in the UK</gtr:impact><gtr:outcomeId>80395A16996</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Validation of alternative protocols for consented collection of human fetal tissue</gtr:description><gtr:id>BD1251B0-C086-4310-B828-4B9F9E295437</gtr:id><gtr:impact>Resolves the outstanding block on limited tissue availability to allow multiple international research and clinical trials to resume.</gtr:impact><gtr:outcomeId>CD8A8553171</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>mTOPs</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>20D881BC-DD16-4CD0-90E9-23BF58802419</gtr:id><gtr:title>Striatal graft projections are influenced by donor cell type and not the immunogenic background.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9dd96bb733c0726221ef84de4144119"><gtr:id>f9dd96bb733c0726221ef84de4144119</gtr:id><gtr:otherNames>Kelly CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>DCD92A76EF3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBF07087-446A-4BB6-B56C-3823CA524C92</gtr:id><gtr:title>Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c7e0ba485891da3707dcf0626d4b234"><gtr:id>3c7e0ba485891da3707dcf0626d4b234</gtr:id><gtr:otherNames>Torres EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>EF4522753D2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F90D378C-F412-46E9-9D72-6BB235312897</gtr:id><gtr:title>Brain-derived neurotrophic factor (BDNF) overexpression in the forebrain results in learning and memory impairments.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7dbd1f8afd3d8670da1474a6bd206f8"><gtr:id>a7dbd1f8afd3d8670da1474a6bd206f8</gtr:id><gtr:otherNames>Cunha C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>63520B7EE6B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED65B25B-06FD-4045-A499-E463B0E1852C</gtr:id><gtr:title>The effects of lateralized training on spontaneous forelimb preference, lesion deficits, and graft-mediated functional recovery after unilateral striatal lesions in rats.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7ddae6c17b0a35ac1b30ce2cfc36223"><gtr:id>f7ddae6c17b0a35ac1b30ce2cfc36223</gtr:id><gtr:otherNames>D?br?ssy MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>6CC1088624A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8687F81E-EBC9-4CE2-86CC-1D334BE534DF</gtr:id><gtr:title>Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f3478c01ebaa05eac3903a180c65bc2"><gtr:id>2f3478c01ebaa05eac3903a180c65bc2</gtr:id><gtr:otherNames>Monville C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>0BAF062CDF1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16E00F4D-56C9-4B57-8625-E63BE2B2A459</gtr:id><gtr:title>The operant serial implicit learning task reveals early onset motor learning deficits in the Hdh knock-in mouse model of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/361fffb92b7a55bf0faec7a2216c7339"><gtr:id>361fffb92b7a55bf0faec7a2216c7339</gtr:id><gtr:otherNames>Trueman RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>C5AEC55462D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>081F71DA-3E08-4821-B3BF-796E34A5E663</gtr:id><gtr:title>Fifty years of dopamine research.</gtr:title><gtr:parentPublicationTitle>Trends in neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6884fbd4d77511ff916691d11f536fc4"><gtr:id>6884fbd4d77511ff916691d11f536fc4</gtr:id><gtr:otherNames>Bj?rklund A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0166-2236</gtr:issn><gtr:outcomeId>D9000A23FC2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34FC4A85-DDF9-4FA9-B316-EA92B9319959</gtr:id><gtr:title>Morphological and cellular changes within embryonic striatal grafts associated with enriched environment and involuntary exercise.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7ddae6c17b0a35ac1b30ce2cfc36223"><gtr:id>f7ddae6c17b0a35ac1b30ce2cfc36223</gtr:id><gtr:otherNames>D?br?ssy MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>4C72C7CAC80</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2E7D42F-DC65-4A93-BF68-E752D613DF14</gtr:id><gtr:title>A simple breeding protocol for the procurement of accurately staged rat donor embryos for neural transplantation.</gtr:title><gtr:parentPublicationTitle>Cell transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/389b1725ef27b94b50fde50afb5471a2"><gtr:id>389b1725ef27b94b50fde50afb5471a2</gtr:id><gtr:otherNames>Weyrauch UM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0963-6897</gtr:issn><gtr:outcomeId>D4B3DBD4463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B9E0082-F596-48A6-BC44-CDB63A55A1DB</gtr:id><gtr:title>Microfluidic chip-based synthesis of alginate microspheres for encapsulation of immortalized human cells.</gtr:title><gtr:parentPublicationTitle>Biomicrofluidics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30ca6017cbbef533f003d2ffafc0d8b7"><gtr:id>30ca6017cbbef533f003d2ffafc0d8b7</gtr:id><gtr:otherNames>Workman VL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-1058</gtr:issn><gtr:outcomeId>6A9023A321F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6F95865-44EE-42A7-8467-8BCE42699737</gtr:id><gtr:title>Brain gene expression correlates with changes in behavior in the R6/1 mouse model of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Genes, brain, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb73a1601c2776118c87e5253b8af8b2"><gtr:id>cb73a1601c2776118c87e5253b8af8b2</gtr:id><gtr:otherNames>Hodges A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1601-183X</gtr:issn><gtr:outcomeId>C0783045ADC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32892EAB-43FD-4A7D-97DC-DFC59D4A35AE</gtr:id><gtr:title>Amphetamine induced rotation in the assessment of lesions and grafts in the unilateral rat model of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c7e0ba485891da3707dcf0626d4b234"><gtr:id>3c7e0ba485891da3707dcf0626d4b234</gtr:id><gtr:otherNames>Torres EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0924-977X</gtr:issn><gtr:outcomeId>B2E3382667B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37A6E66A-4B13-4C49-85CD-307BE20FBD7F</gtr:id><gtr:title>Chapter 55: neural transplantation.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2edda089a98ce18159ce9576c85efbc2"><gtr:id>2edda089a98ce18159ce9576c85efbc2</gtr:id><gtr:otherNames>Dunnett SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>F6889A16260</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>618E86AB-2025-47D1-B4C1-731817DB29FE</gtr:id><gtr:title>Fronto-striatal disconnection disrupts operant delayed alternation performance in the rat.</gtr:title><gtr:parentPublicationTitle>Neuroreport</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/713fd1506e897f8ddfa3facf6d1720f4"><gtr:id>713fd1506e897f8ddfa3facf6d1720f4</gtr:id><gtr:otherNames>White A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0959-4965</gtr:issn><gtr:outcomeId>528F267F1FE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>999869E9-F473-4CEE-A0F2-5DF14EC63F6D</gtr:id><gtr:title>Animal models of Parkinson's disease and L-dopa induced dyskinesia: how close are we to the clinic?</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d27e98166c20bb334efb8e475cb7e1da"><gtr:id>d27e98166c20bb334efb8e475cb7e1da</gtr:id><gtr:otherNames>Lane E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>B1AD2480AEC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E41D47B-6319-4E13-BE2B-E798515AE7AE</gtr:id><gtr:title>Movement without dopamine: striatal dopamine is required to maintain but not to perform learned actions.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2befd6474a45a1a154c5a27941b365c5"><gtr:id>2befd6474a45a1a154c5a27941b365c5</gtr:id><gtr:otherNames>Dowd E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>A00AA7A811E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>751E59A2-1730-419C-8DD4-D63716B5599C</gtr:id><gtr:title>Re-examining the ontogeny of substantia nigra dopamine neurons.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2510202ca1bc2895b5508e552a16f21c"><gtr:id>2510202ca1bc2895b5508e552a16f21c</gtr:id><gtr:otherNames>Gates MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>65C0391C478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCDD7BD4-A793-43D9-B737-996B755E5EE0</gtr:id><gtr:title>Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Brain research bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5642ebb664dd6c35df24e96dd22be6d"><gtr:id>b5642ebb664dd6c35df24e96dd22be6d</gtr:id><gtr:otherNames>Brooks SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0361-9230</gtr:issn><gtr:outcomeId>D774DDAE899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB8E5425-8E00-46D7-890A-90F13872FA09</gtr:id><gtr:title>Lesions of the premotor and supplementary motor areas fail to prevent implicit learning in the operant serial implicit learning task.</gtr:title><gtr:parentPublicationTitle>Brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5642ebb664dd6c35df24e96dd22be6d"><gtr:id>b5642ebb664dd6c35df24e96dd22be6d</gtr:id><gtr:otherNames>Brooks SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8993</gtr:issn><gtr:outcomeId>36697EF94F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F5EDBE8-22E5-411C-9C06-B90D1551B76A</gtr:id><gtr:title>Tests to assess motor phenotype in mice: a user's guide.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5642ebb664dd6c35df24e96dd22be6d"><gtr:id>b5642ebb664dd6c35df24e96dd22be6d</gtr:id><gtr:otherNames>Brooks SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-003X</gtr:issn><gtr:outcomeId>28275604076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9109FCBE-C9D5-4F94-AC79-F6369123CB34</gtr:id><gtr:title>Striatal grafts alleviate bilateral striatal lesion deficits in operant delayed alternation in the rat.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2edda089a98ce18159ce9576c85efbc2"><gtr:id>2edda089a98ce18159ce9576c85efbc2</gtr:id><gtr:otherNames>Dunnett SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>48E7A76B8DD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>998426D3-7C31-49D2-9BD8-A1F0B5EDCCA6</gtr:id><gtr:title>Genetic, temporal and diurnal influences on L-dopa-induced dyskinesia in the 6-OHDA model.</gtr:title><gtr:parentPublicationTitle>Brain research bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f3478c01ebaa05eac3903a180c65bc2"><gtr:id>2f3478c01ebaa05eac3903a180c65bc2</gtr:id><gtr:otherNames>Monville C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0361-9230</gtr:issn><gtr:outcomeId>2B2C1707BB9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DFC105E-2E13-4C98-863B-7B62A2DA01CF</gtr:id><gtr:title>Dopamine neuron systems in the brain: an update.</gtr:title><gtr:parentPublicationTitle>Trends in neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6884fbd4d77511ff916691d11f536fc4"><gtr:id>6884fbd4d77511ff916691d11f536fc4</gtr:id><gtr:otherNames>Bj?rklund A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0166-2236</gtr:issn><gtr:outcomeId>0B94819032F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75E4AFFB-48C2-44F5-9009-A5F2EF00E536</gtr:id><gtr:title>Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c7e0ba485891da3707dcf0626d4b234"><gtr:id>3c7e0ba485891da3707dcf0626d4b234</gtr:id><gtr:otherNames>Torres EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>19D9D28596B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C54B98A-0DB9-4E2E-9428-167EBC05B711</gtr:id><gtr:title>Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>63BC22F5360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7BF9D99-07E7-413A-83EF-9435AEC94AD1</gtr:id><gtr:title>Time course of choice reaction time deficits in the Hdh(Q92) knock-in mouse model of Huntington's disease in the operant serial implicit learning task (SILT).</gtr:title><gtr:parentPublicationTitle>Behavioural brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/361fffb92b7a55bf0faec7a2216c7339"><gtr:id>361fffb92b7a55bf0faec7a2216c7339</gtr:id><gtr:otherNames>Trueman RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0166-4328</gtr:issn><gtr:outcomeId>088EE1F1C3C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C9CFAA4-8E2D-4A3E-92D2-30C867085CE9</gtr:id><gtr:title>Impaired bidirectional synaptic plasticity and procedural memory formation in striatum-specific cAMP response element-binding protein-deficient mice.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5278b8f0a09e2e16cc8b692da4470ede"><gtr:id>5278b8f0a09e2e16cc8b692da4470ede</gtr:id><gtr:otherNames>Pittenger C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>D295941BE98</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6189545C-6444-4F0A-8DA8-CA02D2F724FE</gtr:id><gtr:title>The corridor task: striatal lesion effects and graft-mediated recovery in a model of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Behavioural brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7ddae6c17b0a35ac1b30ce2cfc36223"><gtr:id>f7ddae6c17b0a35ac1b30ce2cfc36223</gtr:id><gtr:otherNames>D?br?ssy MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0166-4328</gtr:issn><gtr:outcomeId>1CACD95AEAC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC1A5426-808B-458B-9988-8E1B7CD7CF49</gtr:id><gtr:title>Rule learning, visuospatial function and motor performance in the Hdh(Q92) knock-in mouse model of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Behavioural brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/361fffb92b7a55bf0faec7a2216c7339"><gtr:id>361fffb92b7a55bf0faec7a2216c7339</gtr:id><gtr:otherNames>Trueman RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0166-4328</gtr:issn><gtr:outcomeId>32806D56422</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0274ED03-DCE0-47B3-B186-801E03A97B60</gtr:id><gtr:title>Potential cellular and regenerative approaches for the treatment of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neuropsychiatric disease and treatment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbe135285b83ddc9d62cae2090f558d2"><gtr:id>cbe135285b83ddc9d62cae2090f558d2</gtr:id><gtr:otherNames>Lane EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1176-6328</gtr:issn><gtr:outcomeId>6654699EB9B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2162DB2D-C5F1-41F0-8305-0AF4AF6E6DB6</gtr:id><gtr:title>Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6d6db473a6f57ebbfeccd1caf60f865"><gtr:id>a6d6db473a6f57ebbfeccd1caf60f865</gtr:id><gtr:otherNames>Kuhn A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>99D98A5635C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A7DCA55-60DE-4D89-AF10-3A377DCAF5C8</gtr:id><gtr:title>Ascorbic acid increases the number of dopamine neurons in vitro and in transplants to the 6-OHDA-lesioned rat brain.</gtr:title><gtr:parentPublicationTitle>Cell transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d0143b39afe8082ac2c1b916b23a709"><gtr:id>3d0143b39afe8082ac2c1b916b23a709</gtr:id><gtr:otherNames>Bagga V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0963-6897</gtr:issn><gtr:outcomeId>4C14B228C62</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E65E40F7-1A96-4CA8-83A8-F9606C557D32</gtr:id><gtr:title>Environmental housing and duration of exposure affect striatal graft morphology in a rodent model of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Cell transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7ddae6c17b0a35ac1b30ce2cfc36223"><gtr:id>f7ddae6c17b0a35ac1b30ce2cfc36223</gtr:id><gtr:otherNames>D?br?ssy MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0963-6897</gtr:issn><gtr:outcomeId>8CEEA48CB0E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AFECF5A-1CCE-40D1-89A4-B0DD08EE43CE</gtr:id><gtr:title>An operant serial implicit learning task (SILT) in rats: task acquisition, performance and the effects of striatal lesions.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7accccd2813254d74ee940a16547fd4"><gtr:id>c7accccd2813254d74ee940a16547fd4</gtr:id><gtr:otherNames>Jay JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>EA9A1E1267A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A2206EE-ED76-44A4-8C3B-40106F5B2AD4</gtr:id><gtr:title>An investigation of the problem of two-layered immunohistochemical staining in paraformaldehyde fixed sections.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c7e0ba485891da3707dcf0626d4b234"><gtr:id>3c7e0ba485891da3707dcf0626d4b234</gtr:id><gtr:otherNames>Torres EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>5849E3C2AD7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D68EAD8E-B92A-46E5-AD92-CB5D49683A1D</gtr:id><gtr:title>A rat embryo staging scale for the generation of donor tissue for neural transplantation.</gtr:title><gtr:parentPublicationTitle>Cell transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c7e0ba485891da3707dcf0626d4b234"><gtr:id>3c7e0ba485891da3707dcf0626d4b234</gtr:id><gtr:otherNames>Torres EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0963-6897</gtr:issn><gtr:outcomeId>BD95863EAC2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E49108F8-D8E7-4754-81FD-313A25AAC7EF</gtr:id><gtr:title>Subtle but progressive cognitive deficits in the female tgHD hemizygote rat as demonstrated by operant SILT performance.</gtr:title><gtr:parentPublicationTitle>Brain research bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1764899a76c3a5379dc9072b78f6a0d"><gtr:id>a1764899a76c3a5379dc9072b78f6a0d</gtr:id><gtr:otherNames>Brooks S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0361-9230</gtr:issn><gtr:outcomeId>6D1465E2BF6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FF80814-7520-44AB-99BD-CD6757CEA7F0</gtr:id><gtr:title>Striatal lesions in the mouse disrupt acquisition and retention, but not implicit learning, in the SILT procedural motor learning task.</gtr:title><gtr:parentPublicationTitle>Brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5642ebb664dd6c35df24e96dd22be6d"><gtr:id>b5642ebb664dd6c35df24e96dd22be6d</gtr:id><gtr:otherNames>Brooks SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-8993</gtr:issn><gtr:outcomeId>83ABD807848</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500794</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>